Moderna CEO Bancel: Future Covid Vaccine Booster Will Likely Target Omicron Variant
Published by ValueWalkFollowing is the unofficial transcript of a CNBC interview with Moderna Inc (NASDAQ:MRNA) CEO Stephane Bancel on CNBC’s “SquRead More…
Day: April 7, 2019
Junshi Biosciences and Coherus Expand Immuno-Oncology Collaboration to Include TIGIT-Targeted Antibody
Junshi Biosciences and Coherus plan to evaluate the toripalimab + JS006 combination in clinical trials in multiple tumor types
Combinations of PD-1Read More…
General Fusion achieves critical technology milestone for practical fusion power
Successful performance of plasma compression prototype confirms path to commercialization General Fusion’s plasma compression prototype GeneRead More…
2022 A4BET® Worldwide Domain & Trademark Sale
BEIJING and LONDON and PARIS and SAN FRANCISCO, Jan. 10, 2022 (GLOBE NEWSWIRE) — After overwhelming demand, creative offers and global inquiresRead More…
British Fishing Tackle & Bait Scales Order Fulfillment Processing 250% with Descartes Ecommerce WMS
CHIPPENHAM, United Kingdom, Jan. 10, 2022 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX: DSG), the global leader in uniting lRead More…
Khondrion completes enrolment in KHENERGYZE Phase IIb trial evaluating sonlicromanol in adult patients with MELAS spectrum disorders
Khondrion completes enrolment in KHENERGYZE Phase IIb trial evaluating sonlicromanol in adult patients with MELAS spectrum disorders NIJMEGEN, the NRead More…
MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio
MeMed raises $93M to accelerate commercialization of its
host immune-response product portfolio
MeMed BV® test recently cleared for use by US FDA toRead More…
Nyxoah Provides General Corporate Update
Nyxoah Provides General Corporate Update
Transformational 2021 positions Nyxoah for further clinical, regulatory, and commercial milestones in 2022
MoRead More…